TrialInternational journal of chronic obstructive pulmonary disease2016

A randomized, parallel-group study to evaluate the efficacy of umeclidinium/vilanterol 62.5/25 μg on health-related quality of life in patients with COPD.

Thomas M Siler et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.